Your browser doesn't support javascript.
loading
Melanoma Antigen Family A (MAGE A) as Promising Biomarkers and Therapeutic Targets in Bladder Cancer.
Verma, Shiv; Swain, Diya; Kushwaha, Prem Prakash; Brahmbhatt, Smit; Gupta, Karishma; Sundi, Debasish; Gupta, Sanjay.
Afiliação
  • Verma S; Department of Urology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
  • Swain D; The Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.
  • Kushwaha PP; College of Arts and Sciences, Case Western Reserve University, Cleveland, OH 44106, USA.
  • Brahmbhatt S; Department of Urology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
  • Gupta K; The Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.
  • Sundi D; College of Arts and Sciences, Case Western Reserve University, Cleveland, OH 44106, USA.
  • Gupta S; Department of Urology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Cancers (Basel) ; 16(2)2024 Jan 05.
Article em En | MEDLINE | ID: mdl-38254738
ABSTRACT
The Melanoma Antigen Gene (MAGE) is a large family of highly conserved proteins that share a common MAGE homology domain. Interestingly, many MAGE family members exhibit restricted expression in reproductive tissues but are abnormally expressed in various human malignancies, including bladder cancer, which is a common urinary malignancy associated with high morbidity and mortality rates. The recent literature suggests a more prominent role for MAGEA family members in driving bladder tumorigenesis. This review highlights the role of MAGEA proteins, the potential for them to serve as diagnostic or prognostic biomarker(s), and as therapeutic targets for bladder cancer.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos